FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2948786412> ?p ?o ?g. }

• W2948786412 endingPage "1778" @default.
• W2948786412 startingPage "1770" @default.
• W2948786412 abstract "Secondary AML (s-AML), including AML with an antecedent hematologic disorder (AHD-AML) and therapy-related AML (t-AML), constitutes a large proportion of patients with AML and is considered to confer a dismal prognosis. The role of allogeneic hematopoietic cell transplantation (HCT) in patients with s-AML and the extent to which HCT is performed in these patients has been little studied to date. We used the population-based Swedish AML Registry comprising 3337 intensively treated adult patients over a 17-year period to study the role of HCT within the group of patients with s-AML as well as compared with patients with de novo AML. HCT was performed in 576 patients (22%) with de novo AML, in 74 patients (17%) with AHD-AML, and in 57 patients (20%) with t-AML. At 5 years after diagnosis, there were no survivors among patients with previous myeloproliferative neoplasms who did not undergo HCT, and corresponding survival for patients with antecedent myelodysplastic syndromes and t-AML was and 2% and 4%, respectively. HCT was compared with chemotherapy consolidation in s-AML using 3 models: (1) a 200-day landmark analysis, in which HCT was favorable compared with conventional consolidation (P = .04, log-rank test); (2) a multivariable Cox regression with HCT as a time-dependent variable, in which the hazard ratio for mortality was 0.73 (95% confidence interval, 0.64 to 0.83) for HCT and favored HCT in all subgroups; and (3) a propensity score matching analysis, in which the 5-year overall survival (OS) and relapse-free survival in patients with s-AML in first complete remission (CR1) was 48% and 43%, respectively, for patients undergoing HCT versus 20% and 21%, respectively, for those receiving chemotherapy consolidation (P = .01 and .02, respectively, log-rank test). Our observational data suggest that HCT improves survival and offers the only realistic curative treatment option in patients with s-AML." @default.
• W2948786412 created "2019-06-14" @default.
• W2948786412 creator A5002001139 @default.
• W2948786412 creator A5004083002 @default.
• W2948786412 creator A5006337337 @default.
• W2948786412 creator A5008700475 @default.
• W2948786412 creator A5008994740 @default.
• W2948786412 creator A5028102234 @default.
• W2948786412 creator A5030094794 @default.
• W2948786412 creator A5045598354 @default.
• W2948786412 creator A5057640941 @default.
• W2948786412 creator A5066936951 @default.
• W2948786412 creator A5069908069 @default.
• W2948786412 creator A5074033554 @default.
• W2948786412 creator A5088708221 @default.
• W2948786412 date "2019-09-01" @default.
• W2948786412 modified "2023-10-16" @default.
• W2948786412 title "Secondary Acute Myeloid Leukemia and the Role of Allogeneic Stem Cell Transplantation in a Population-Based Setting" @default.
• W2948786412 cites W1512898985 @default.
• W2948786412 cites W1856810180 @default.
• W2948786412 cites W1971211622 @default.
• W2948786412 cites W1982831088 @default.
• W2948786412 cites W2014357452 @default.
• W2948786412 cites W2027313932 @default.
• W2948786412 cites W2038981426 @default.
• W2948786412 cites W2057051793 @default.
• W2948786412 cites W2058188142 @default.
• W2948786412 cites W2074425311 @default.
• W2948786412 cites W2079729552 @default.
• W2948786412 cites W2090352304 @default.
• W2948786412 cites W2090915775 @default.
• W2948786412 cites W2107027906 @default.
• W2948786412 cites W2111724321 @default.
• W2948786412 cites W2116858301 @default.
• W2948786412 cites W2118270328 @default.
• W2948786412 cites W2123331484 @default.
• W2948786412 cites W2128812336 @default.
• W2948786412 cites W2152849583 @default.
• W2948786412 cites W2160820093 @default.
• W2948786412 cites W2235843447 @default.
• W2948786412 cites W2324143682 @default.
• W2948786412 cites W2559537906 @default.
• W2948786412 cites W2589411765 @default.
• W2948786412 cites W2761154221 @default.
• W2948786412 cites W2765711144 @default.
• W2948786412 cites W2801044371 @default.
• W2948786412 doi "https://doi.org/10.1016/j.bbmt.2019.05.038" @default.
• W2948786412 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31176789" @default.
• W2948786412 hasPublicationYear "2019" @default.
• W2948786412 type Work @default.
• W2948786412 sameAs 2948786412 @default.
• W2948786412 citedByCount "21" @default.
• W2948786412 countsByYear W29487864122020 @default.
• W2948786412 countsByYear W29487864122021 @default.
• W2948786412 countsByYear W29487864122022 @default.
• W2948786412 countsByYear W29487864122023 @default.
• W2948786412 crossrefType "journal-article" @default.
• W2948786412 hasAuthorship W2948786412A5002001139 @default.
• W2948786412 hasAuthorship W2948786412A5004083002 @default.
• W2948786412 hasAuthorship W2948786412A5006337337 @default.
• W2948786412 hasAuthorship W2948786412A5008700475 @default.
• W2948786412 hasAuthorship W2948786412A5008994740 @default.
• W2948786412 hasAuthorship W2948786412A5028102234 @default.
• W2948786412 hasAuthorship W2948786412A5030094794 @default.
• W2948786412 hasAuthorship W2948786412A5045598354 @default.
• W2948786412 hasAuthorship W2948786412A5057640941 @default.
• W2948786412 hasAuthorship W2948786412A5066936951 @default.
• W2948786412 hasAuthorship W2948786412A5069908069 @default.
• W2948786412 hasAuthorship W2948786412A5074033554 @default.
• W2948786412 hasAuthorship W2948786412A5088708221 @default.
• W2948786412 hasBestOaLocation W29487864121 @default.
• W2948786412 hasConcept C126322002 @default.
• W2948786412 hasConcept C143998085 @default.
• W2948786412 hasConcept C207103383 @default.
• W2948786412 hasConcept C2777408962 @default.
• W2948786412 hasConcept C2778729363 @default.
• W2948786412 hasConcept C2908647359 @default.
• W2948786412 hasConcept C2911091166 @default.
• W2948786412 hasConcept C44249647 @default.
• W2948786412 hasConcept C50382708 @default.
• W2948786412 hasConcept C71924100 @default.
• W2948786412 hasConcept C99454951 @default.
• W2948786412 hasConceptScore W2948786412C126322002 @default.
• W2948786412 hasConceptScore W2948786412C143998085 @default.
• W2948786412 hasConceptScore W2948786412C207103383 @default.
• W2948786412 hasConceptScore W2948786412C2777408962 @default.
• W2948786412 hasConceptScore W2948786412C2778729363 @default.
• W2948786412 hasConceptScore W2948786412C2908647359 @default.
• W2948786412 hasConceptScore W2948786412C2911091166 @default.
• W2948786412 hasConceptScore W2948786412C44249647 @default.
• W2948786412 hasConceptScore W2948786412C50382708 @default.
• W2948786412 hasConceptScore W2948786412C71924100 @default.
• W2948786412 hasConceptScore W2948786412C99454951 @default.
• W2948786412 hasFunder F4320313607 @default.
• W2948786412 hasIssue "9" @default.
• W2948786412 hasLocation W29487864121 @default.
• W2948786412 hasLocation W29487864122 @default.
• W2948786412 hasOpenAccess W2948786412 @default.

• next